Kristie Anne Krawczyk

Title: The Innovations of Kristie Anne Krawczyk

Introduction

Kristie Anne Krawczyk is an accomplished inventor based in Gowanda, NY (US). He has made significant contributions to the field of biomedical research, particularly in the study of HIV. His innovative work has led to the development of a patent that addresses critical aspects of HIV entry into target cells.

Latest Patents

Krawczyk holds a patent related to HIV chemokines. The patent discloses a gene comprising an open reading frame encoded on the plus strand of the pro-viral DNA, located in the region of HIV-1 long terminal repeat. This gene encodes a protein that shares structural motifs with chemokine proteins. Depending on the ribosomal frameshift, multiple proteins may be translated from the antisense RNA. The protein exhibits similarity with chemokine SDF-1 and may function as a cofactor with gp120 in facilitating the binding and entry of HIV into target cells. He has 1 patent to his name.

Career Highlights

Krawczyk is affiliated with the State University of New York, where he conducts research and contributes to the academic community. His work has garnered attention for its potential impact on HIV treatment and understanding.

Collaborations

Some of his notable coworkers include Linda B Ludwig and Julian L Ambrus, Jr. Their collaborative efforts have further advanced research in the field of HIV and related studies.

Conclusion

Kristie Anne Krawczyk's innovative contributions to HIV research highlight the importance of scientific inquiry in addressing global health challenges. His work continues to inspire future advancements in the field.